A super-strong weight loss medicine that works really well but can upset your tummy
Efficacy and safety of retatrutide, a novel GLP-1, GIP, and glucagon receptor agonist for obesity treatment: a systematic review and meta-analysis of randomized controlled trials
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Surprising Findings
No significant difference in overall adverse events between retatrutide and placebo groups (RR: 1.11, p = 0.24), despite clear increases in GI side effects.
Even though nausea and vomiting were clearly more common, the overall rate of adverse events didn’t reach statistical significance—suggesting side effects may be tolerable or underreported.
Practical Takeaways
Talk to your doctor about emerging weight-loss medications if you have obesity or type 2 diabetes and haven’t responded to current treatments.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Surprising Findings
No significant difference in overall adverse events between retatrutide and placebo groups (RR: 1.11, p = 0.24), despite clear increases in GI side effects.
Even though nausea and vomiting were clearly more common, the overall rate of adverse events didn’t reach statistical significance—suggesting side effects may be tolerable or underreported.
Practical Takeaways
Talk to your doctor about emerging weight-loss medications if you have obesity or type 2 diabetes and haven’t responded to current treatments.
Publication
Journal
Baylor University Medical Center Proceedings
Year
2025
Authors
Alaa Abdrabou Abouelmagd, Amro Mamdouh Abdelrehim, Mohamed Nabih Bashir, Fares Abdelsalam, Ahmed Marey, Y. Tanas, Duha Milad Abuklish, M. M. Belal
Related Content
Claims (8)
A drug called retatrutide helps people lose a lot of weight—sometimes over 70 pounds—by targeting certain hormones, but it works so well that it can cause unexpected health problems.
A drug called retatrutide probably helps people with obesity or type 2 diabetes lose about 14% of their body weight when given as a weekly shot for up to a year, and higher doses seem to lead to more weight loss.
This drug called retatrutide probably helps people with obesity or type 2 diabetes control their blood sugar better, especially if they take a higher dose.
Taking a drug called retatrutide every week for about 6 to 12 months probably helps people with obesity or type 2 diabetes lose belly fat and drop their BMI by noticeable amounts.
Taking a drug called retatrutide once a week might lower blood pressure in people with obesity or type 2 diabetes, which could help protect their heart over time.